ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Brooklyn ImmunoTherapeutics Inc

Brooklyn ImmunoTherapeutics Inc (BTX)

9.79
0.00
(0.00%)
At close: December 26 4:00PM
9.79
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
9.79
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
9.79
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,410,000
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-4.01
Revenue
68k
Net Profit
-21.68M

About Brooklyn ImmunoTherapeutics Inc

Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immu... Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. Show more

Sector
Pharmaceutical Preparations
Industry
Television Broadcast Station
Website
Headquarters
Wilmington, Delaware, USA
Founded
2022

BTX Latest News

Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial Results

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing...

Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq

NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Reports Inducement Grants

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer

NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts

Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts PR Newswire CAMBRIDGE, Mass., Sept. 15, 2021 CAMBRIDGE, Mass., Sept...

Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET

BROOKLYN, N.Y., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine...

Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience

NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum

BROOKLYN, N.Y., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and...

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021

NEW YORK, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

BTX - Frequently Asked Questions (FAQ)

What is the current Brooklyn ImmunoTherapeut... share price?
The current share price of Brooklyn ImmunoTherapeut... is $ 9.79
How many Brooklyn ImmunoTherapeut... shares are in issue?
Brooklyn ImmunoTherapeut... has 5,410,000 shares in issue
What is the market cap of Brooklyn ImmunoTherapeut...?
The market capitalisation of Brooklyn ImmunoTherapeut... is USD 52.96M
What is the 1 year trading range for Brooklyn ImmunoTherapeut... share price?
Brooklyn ImmunoTherapeut... has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Brooklyn ImmunoTherapeut...?
The price to earnings ratio of Brooklyn ImmunoTherapeut... is -0.07
What is the cash to sales ratio of Brooklyn ImmunoTherapeut...?
The cash to sales ratio of Brooklyn ImmunoTherapeut... is 23.02
What is the reporting currency for Brooklyn ImmunoTherapeut...?
Brooklyn ImmunoTherapeut... reports financial results in USD
What is the latest annual turnover for Brooklyn ImmunoTherapeut...?
The latest annual turnover of Brooklyn ImmunoTherapeut... is USD 68k
What is the latest annual profit for Brooklyn ImmunoTherapeut...?
The latest annual profit of Brooklyn ImmunoTherapeut... is USD -21.68M
What is the registered address of Brooklyn ImmunoTherapeut...?
The registered address for Brooklyn ImmunoTherapeut... is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Brooklyn ImmunoTherapeut... website address?
The website address for Brooklyn ImmunoTherapeut... is eternatx.com
Which industry sector does Brooklyn ImmunoTherapeut... operate in?
Brooklyn ImmunoTherapeut... operates in the TELEVISION BROADCAST STATION sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LODEComstock Inc
$ 0.685
(21.78%)
4.66M
ARENArena Group Holdings Inc
$ 1.68
(18.31%)
42.2k
ITPIT Tech Packaging Inc
$ 0.3299
(17.61%)
139.24k
OSTXOS Therapies Incorporated
$ 6.00
(17.53%)
1.73k
OPTTOcean Power Technologies Inc
$ 0.52
(14.76%)
4.77M
MMAMixed Martial Arts Group Limited
$ 1.55
(-11.43%)
2.61k
YCBDcbdMD Inc
$ 0.33
(-8.59%)
4.81k
PTNPalatin Technologies Inc New
$ 1.02
(-8.11%)
5.28k
BQBoqii Holding Limited
$ 0.3384
(-7.26%)
38.63k
KNWKnow Labs Inc
$ 0.1584
(-5.43%)
6.54k
SPYSPDR S&P 500
$ 600.96
(-0.06%)
15.83M
IVViShares Core S&P 500
$ 604.09
(0.00%)
7.31M
OPTTOcean Power Technologies Inc
$ 0.52
(14.76%)
4.77M
LODEComstock Inc
$ 0.685
(21.78%)
4.66M
FXIiShares China Large Cap
$ 31.17
(0.16%)
3.26M

Discussion

View Full Feed
RIGATONI RIGATONI 28 seconds ago
LODE .705 with 182k buy ~Rig
rodeoup rodeoup 42 seconds ago
In all my years of trading, this is the first time I’ve ever only held one company on the OTC. Call it stupid, uninformed or extremely smart. I’m betting on extremely smart, because I know what I’ve seen, I know what I’ve been told, I know what I’ve heard, and I know what I’ve researched. For me 20
NBRI
Diamondhands45 Diamondhands45 53 seconds ago
Holding 30 since .0009 there 
i_like_bb_stock i_like_bb_stock 54 seconds ago
CNEY moving now usually a banger the following day 
CNEY
i_like_bb_stock i_like_bb_stock 3 minutes ago
CNEY moving now usually a banger the following day 
CNEY
m$teamworkotc m$teamworkotc 4 minutes ago
0015 tommorrow?
HMBL
Elroy Jetson Elroy Jetson 4 minutes ago
That's why Republicans feel such an urgent need to surrender to Vladimir Putin as soon as possible.

It's hard to believe Mike Pompeo has been frozen out of this new administration, after he had formulated such an astoundingly straight-forward surrender plan.

I suppose T
georgie18 georgie18 7 minutes ago
Yes I see...thanks...careful though...🥳... https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=333-273934
QSI
imbellish imbellish 7 minutes ago
https://abcnews.go.com/US/wireStory/nebraska-man-lost-home-588-debt-back-117125341
FNMA
thehawk72 thehawk72 7 minutes ago
2024....can't do this another year. When was the last time we heard from Ken...April, March?
WDLF
EpicNavigator33 EpicNavigator33 7 minutes ago
Some people pay good money to get bent over a barrel lol
HMBL
rx7171 rx7171 8 minutes ago
Can we get the peer review article out prior to JPM?
Priming the pump for Missling’s long presentation in the biggest hall in the house.
JPM
Monroe1 Monroe1 8 minutes ago
hahahahah sure thing buddy. scratch the fake news barrel bottom. losers just can't get over it. some though have seen the light.
Senator Joe Manchin, once a lifelong Democrat, departs from the Senate with a scathing critique of the Democratic Party and a call for a centrist movement.
A
skitahoe skitahoe 8 minutes ago
I believe that if you believe in what management is doing you understand that they have a plan for growing the company, and it's stock price, and it requires the dilution they're doing. If you don't believe that, why be invested in the stock.

To me, far to many people are only concer
CRTG
Joelzee Joelzee 9 minutes ago
Right. Makes me wish I bought more. 
EOSE
havnagoodtime havnagoodtime 9 minutes ago
Who is violating IHUB's terms of service by using two different aliases? Who has exposed them and how have they been exposed? Is there a verifiable source to such evidence? If not, than the accusation is all speculation. Of course this is an opinion forum so you are free to contribute your opinion,
DPLS
Stockman1010101 Stockman1010101 9 minutes ago
AMC stock is a POS dog with fleas stock. AA is looking to drop the AMC stock price lower. AA will do anything to help his buddies (the shorts) make money at the expense of the longs. This AMC is run by a criminal liar who does not care if he wipes out his shareholders. In fact he is looking forward
AMC
mike_dotcom mike_dotcom 9 minutes ago
This ain't no game.
AVXL
EpicNavigator33 EpicNavigator33 10 minutes ago
No I may have sat at -26k value for awhile but definitely didn’t lose anything… as one does not take a loss or gain until they actually sell
HMBL
crazy horse 0 crazy horse 0 10 minutes ago
Yes for sure CJ

I remember. I miss her!

On 12/26/17 this board was created by myself and Mr40. That was Seven years ago! It seems like yesterday.

We all hope Mr40 and her little dog Remy are in good spirits and in good hands.
Hitman970 Hitman970 10 minutes ago
Use instantcheckmate
NWPN
Elonlies Elonlies 10 minutes ago
The majority of what you just said about RDGL is absolute Poppycock. Nonsensical in some ways. Your 2 cents is scattered in ways a short seller would love. I recommend shareholders DISREGARD THIS POST-- What you just said about RDGL can be likened to stating everyone who goes swimming will possibly
RDGL
dig4gold dig4gold 10 minutes ago
Well I hope for everyone still here it happens. It seems like a really good group of people.
CGAC
236T568 236T568 10 minutes ago
Laura Loomer points out that Elon Musk has hired non-American citizens for "entry level" roles at Tesla using the database that lists the salaries of H1B visa holders.


https://x.com/ArtCandee/status/1872400801337123221
RIGATONI RIGATONI 10 minutes ago
.70 with another 60K ask slap ~Rig